Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a specific type of pulmonary hypertension (PH) and the major component of Group 4 pulmonary hypertension (PH). It is caused by pulmonary vasculature obstruction that leads to a progressive increase in pulmonary vascular resistance and, ultimately, to failure of the right ventricle. Pulmonary thromboendarterectomy (PEA) is the only definitive therapy, so a timely diagnosis and early referral to a specialized PEA center to determine candidacy is prudent for a favorable outcome. Percutaneous balloon pulmonary angioplasty (BPA) has a potential role in patients unsuitable for PEA. Medical therapy with riociguat is the only PH-specific medical therapy currently approved for the treatment of inoperable or persistent CTEPH. This review article aims to revisit CTEPH succinctly with a review of prevailing literature.

Highlights

  • If the V/Q scan is suggestive of Chronic thromboembolic pulmonary hypertension (CTEPH), additional testing is required with right heart catheterization (RHC) and pulmonary angiography

  • Lifelong anticoagulation is recommended for all patients with CTEPH [1,2]

  • Balloon Angioplasty (BPA) is mainly used in patients with inoperable CTEPH [40,41]

Read more

Summary

Introduction

The 6th world symposium on pulmonary hypertension (PH) in 2018 has defined PH as an elevated mean pulmonary artery pressure (mPAP) ≥ 20 mmHg at rest, pulmonary capillary wedge pressure < 15 mmHg, and pulmonary vascular resistance (PVR) ≥ 3 Wood. PH can be further subdivided into 5 groups (Table 1). Chronic thromboembolic pulmonary hypertension (CTEPH) belongs to Group 4 of the PH classification. CTEPH is defined as an obstruction of the pulmonary arterial vasculature secondary to single or recurrent episodes of pulmonary embolism (PE) [2]. It is a distinct and infrequently diagnosed entity of PH that is progressive and can be fatal if left untreated

Epidemiology
Main Results
Pathophysiology of CTEPH
Predisposing Factors for CTEPH
Clinical Features
Diagnostic Evaluation in CTEPH
Role of Right Heart Catheterization and Pulmonary Angiography
Management of CTEPH
Pulmonary
PH-Targeted Medical Therapy in CTEPH
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call